Spravato®Registry-verifiedPrivate-market model
Klinikum Nürnberg — Klinik für Psychiatrie und Psychotherapie (Campus Nord)
Nürnberg, Germany
Treatment & access
- Treatments offeredesketamine (Spravato)
- Access routepublic_reimbursed
- Price informationCovered by GKV for on-label TRD; see country guide
- ReimbursementGKV — hospital financing for day-clinic/inpatient induction; outpatient maintenance via PIA Campus Nord for up to 6 months How reimbursement works in Europe →
- Phone+49 911 398-9074
- Websitehttps://www.klinikum-nuernberg.de/behandlung/seelische-gesundheit/
About this provider
Klinikum Nürnberg is one of Europe's largest municipal hospitals and a teaching hospital of Paracelsus Medical University. Its Department of Psychiatry and Psychotherapy at Campus Nord publishes a referrer newsletter on its own domain that sets out a formal Spravato pathway: intranasal esketamine delivered in a day-clinic or inpatient setting over three to six weeks, followed where successful by outpatient maintenance for up to six months through the hospital's psychiatric institute outpatient clinic (PIA). A dedicated referral phone line and email are published.
Verification
- License / registryPublic trial registry (ClinicalTrials.gov / EU CTIS)
- Sourcehttps://www.klinikum-nuernberg.de/fileadmin/user_upload/Flyer_Dokumente_Verwaltung/Unternehmenskommunikation_UK/Newsletter_Kliniken/Newsletter_Psychiatrie_Psychotherapie_2023-1.pdf
- Last verified